MRL-SYKi |
MRL-SYKi : Inhibitor of SYK
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SYK |
|
|
Inhibitor
100 nM
Selectivity
In Vitro Selectivity Assessment
ZAP70
Gene ID: P43403
Organism: Homo sapiens
Family: Tyr protein kinase family
Selectivity Assessment Description:
Selectivity within target family - Based on an internal assessment we found the closely related kina ...
Potency Cellular
In Vitro
SYK
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.6019/CHEMBL4507285
In Vivo Validations
Rat
Dose: 1-30 mg/Kg
Route of delivery:
Oral
Plasma half life:
2.2 h
Systemic clearance:
7-8 mL/min/kg
Fb :
94.7%
Bioavailability:
20%
DOI Reference: 10.6019/CHEMBL4507285
Dog
Dose: 1-30 mg/Kg
Route of delivery:
Oral
Plasma half life:
3.6 h
Systemic clearance:
7-8 mL/min/kg
Fb :
90.9%
Bioavailability:
54%
DOI Reference: 10.6019/CHEMBL4507285
Negative Control Compounds
MRL-SYKi-NC
Notes: The negative control is 1000-fold less potent biochemically and shows no activity in cells @ 10µM; Note: Shows off-target activity in the GPCR scan: the closest hit is GABA/PBR (Ki = 774 nM)
Chemical Information
| Molecular Formula | C24H28N4O3S |
| SMILEs | Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1 |
| InChI | InChI=1S/C24H28N4O3S/c1-14-9-16(11-17(10-14)28-22-25-8-6-15(2)27-22)19-12-26-21(32-19)24(31)7-5-18(20(29)30)23(3,4)13-24/h6,8-12,18,31H,5,7,13H2,1-4H3,(H,29,30)(H,25,27,28)/t18-,24-/m1/s1 |
| Molecular weight | 452.19 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 3 |
| Atoms | 60 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.